Attached files
file | filename |
---|---|
8-K - FORM 8-K - MiddleBrook Pharmaceuticals, Inc. | c11164e8vk.htm |
Exhibit 99.1
UNITED STATES BANKRUPTCY COURT
DISTRICT OF DELAWARE
DISTRICT OF DELAWARE
In re MiddleBrook Pharmaceuticals, Inc.
|
Case No. 10-11485 | |
Debtor
|
Reporting Period: December 1 December 31, 2010 |
MONTHLY OPERATING REPORT
File with Court and submit copy to United States Trustee within 20 days after end of month
File with Court and submit copy to United States Trustee within 20 days after end of month
Submit copy of report to any official committee appointed in the case.
Document | Explanation | Affidavit/Supplement | ||||||
REQUIRED DOCUMENTS | Form No. | Attached | Attached | Attached | ||||
Certifications |
||||||||
Schedule of Cash Receipts and Disbursements |
MOR-1 | X | ||||||
Bank Reconciliation (or copies of debtors bank
reconciliations) |
see certifications | X | ||||||
Schedule of Professional Fees Paid |
MOR-1b | X | ||||||
Copies of bank statements |
see certifications | X | ||||||
Cash disbursements journals |
X | |||||||
Statement of Operations |
MOR-2 | X | ||||||
Balance Sheet |
MOR-3 | X | ||||||
Status of Postpetition Taxes |
Taxes | X | ||||||
Copies of IRS Form 6123 or payment receipt |
||||||||
Copies of tax returns filed during reporting period |
||||||||
Summary of Unpaid Postpetition Debts |
MOR-4 | X | ||||||
Listing of aged accounts payable |
MOR-4 | X | ||||||
Accounts Receivable Reconciliation and Aging |
MOR-5 | X | ||||||
Debtor Questionnaire |
MOR-5 | X | X |
I declare under penalty of perjury (28 U.S.C. Section 1746) that this report
and the attached documents
are true and correct to the best of my knowledge and belief.
/s/ Ron Glass
|
January 18, 2010
|
|||
Ron Glass
|
Plan Administrator
|
* | Authorized individual must be an officer, director or shareholder if debtor is a corporation; a partner if debtor is a partnership; a manager or member if debtor is a limited liability company. |
The Debtors Modified Plan of Liquidation (the Plan) was confirmed on December 30, 2010. The Plan became
effective on January 3, 2011.
MOR
(04/07)
(04/07)
UNITED STATES BANKRUPTCY COURT
DISTRICT OF DELAWARE
DISTRICT OF DELAWARE
In re MiddleBrook Pharmaceuticals, Inc.
|
Case No. 10-11485 | |
Debtor
|
Reporting Period: December 1 December 31, 2010 |
CERTIFICATIONS
A. Bank Reconciliation Certification
The undersigned verifies that, to my knowledge, all of the Debtors December 31, 2010 bank balances have been
reconciled in an accurate and timely manner.
Bank Name | Account | Book Balance | ||||||
Capital One Bank |
****8899 | $ | 2,728,326.07 | |||||
Capital One Bank |
****8910 | $ | 10,000.00 | |||||
Capital One Bank |
****9471 | $ | 13,525,679.32 |
B. Post-petition Taxes Certification
The undersigned verifies that, to my knowledge, all post-petition tax obligations, including but not limited to
payroll, real property, income, franchise and other taxes have been paid to the proper taxing authority when
due.
/s/ Ronald L. Glass
|
January 18, 2010
|
|||
Ronald L. Glass
|
Plan Administrator
|
|||
Printed Name of Authorized Individual
|
Title of Authorized Individual |
In re: MiddleBrook Pharmaceuticals, Inc.
|
Case No. 10-11485 | |
Debtor
|
Reporting Period: December 1 December 31, 2010 |
MOR 1
Current Month | Cumulative Filing to Date | |||||||||||||||
Actual | Forecast | Actual | Forecast | |||||||||||||
Beginning Date |
1-Dec-10 | 1-Dec-10 | 3-May-10 | 3-May-10 | ||||||||||||
Ending Date |
31-Dec-10 | 31-Dec-10 | 31-Dec-10 | 31-Dec-10 | ||||||||||||
Cash Beginning Balance |
$ | 16,497,862 | $ | 16,497,573 | $ | 5,257,718 | $ | 5,269,539 | ||||||||
Receipts |
||||||||||||||||
Lockbox |
| | 645,880 | 299,859 | ||||||||||||
Misc Deposits |
34,127 | 11,822 | 17,709,213 | 18,700,226 | ||||||||||||
Total Receipts |
$ | 34,127 | $ | 11,822 | $ | 18,355,093 | $ | 19,000,085 | ||||||||
Operating Disbursements |
||||||||||||||||
Gleacher |
| | (712,514 | ) | | |||||||||||
Dr Directory |
| | (77,948 | ) | (127,774 | ) | ||||||||||
Legal & Deal fees |
(103,218 | ) | (424,218 | ) | (1,190,420 | ) | (1,305,576 | ) | ||||||||
Par Litigation (additional expense) |
(6,673 | ) | (50,000 | ) | (6,673 | ) | (50,000 | ) | ||||||||
KCC LLC |
| (45,000 | ) | (65,501 | ) | (175,513 | ) | |||||||||
Plan Administrator |
| (25,000 | ) | | (25,000 | ) | ||||||||||
Creditors Committee Counsel & FA |
(57,157 | ) | (62,603 | ) | (330,695 | ) | (607,669 | ) | ||||||||
Equity Committee Counsel |
| (150,000 | ) | (94,294 | ) | (394,294 | ) | |||||||||
Other Professional Fees |
| | | (347,480 | ) | |||||||||||
Payroll |
(20,834 | ) | (41,000 | ) | (1,198,175 | ) | (1,491,830 | ) | ||||||||
Benefits |
(871 | ) | | (263,923 | ) | (206,567 | ) | |||||||||
Severance |
| | | | ||||||||||||
Invoices in A/P Aging |
(43,406 | ) | (38,860 | ) | (1,261,965 | ) | (1,198,257 | ) | ||||||||
Misc (TX rent, Insurance, ICS) |
(5,958 | ) | (10,370 | ) | (1,031,792 | ) | (360,846 | ) | ||||||||
Other |
(29,866 | ) | (46,800 | ) | (1,119,655 | ) | (1,287,258 | ) | ||||||||
voided checks |
| | 4,749 | | ||||||||||||
Total Operating Disbursements |
$ | (267,983 | ) | $ | (893,851 | ) | $ | (7,348,805 | ) | $ | (7,578,064 | ) | ||||
Net Operating Cash Flow |
$ | (233,856 | ) | $ | (882,029 | ) | $ | 11,006,287 | $ | 11,422,021 | ||||||
Non-Operating Disbursements |
||||||||||||||||
Capex |
||||||||||||||||
Professional Fees |
||||||||||||||||
Total Non-Operating Disbursements |
$ | | $ | | $ | | $ | | ||||||||
Net Operating Cash Flow Before Financing |
$ | (233,856 | ) | $ | (882,029 | ) | $ | 11,006,287 | $ | 11,422,021 | ||||||
Financing Activities |
||||||||||||||||
Interest Payments |
||||||||||||||||
Financing Activities |
$ | | $ | | $ | | $ | | ||||||||
Cash Flow |
$ | (233,856 | ) | $ | (882,029 | ) | $ | 11,006,287 | $ | 11,422,021 | ||||||
Ending Cash Balance (per books) |
$ | 16,264,005 | $ | 15,615,544 | $ | 16,264,005 | $ | 16,691,560 | ||||||||
DISBURSEMENTS FOR CALCULATING U.S. TRUSTEE QUARTERLY FEES: (FROM CURRENT MONTH ACTUAL COLUMN) | ||||
TOTAL DISBURSEMENTS |
$ | (267,983 | ) | |
LESS: TRANSFERS TO DEBTOR IN POSSESSION ACCOUNTS |
$ | 0 | ||
PLUS: ESTATE DISBURSEMENTS MADE BY OUTSIDE SOURCES (i.e. from escrow accounts) |
$ | 0 | ||
TOTAL DISBURSEMENTS FOR CALCULATING U.S. TRUSTEE QUARTERLY FEES |
$ | (267,983 | ) | |
In re: MiddleBrook Pharmaceuticals, Inc.
|
Case No. 10-11485 | |
Debtor
|
Reporting Period: December 1 December 31, 2010 |
Disbursements Journal
Checks cut during period
GL Posting | Checkbook | |||||||||||
Date | Source Document | Amount | CM Trx Number | Voided | Paid ToRcvd From | |||||||
12/16/2010 |
PMCHK | $ | 2,272.83 | 5334 | No | A1 DOCUMENT SOLUTIONS, LLC | ||||||
12/9/2010 |
PMCHK | $ | 103,217.87 | 5333 | No | Alston & Bird LLP | ||||||
12/9/2010 |
PMCHK | $ | 1,071.00 | 5324 | No | American Stock Transfer & Trust Co | ||||||
12/16/2010 |
PMCHK | $ | 154.47 | 5335 | No | AT&T Mobility | ||||||
12/9/2010 |
PMCHK | $ | 649.50 | 5325 | No | AZTEC SYSTEMS | ||||||
12/16/2010 |
PMCHK | $ | 663.04 | 5336 | No | AZTEC SYSTEMS | ||||||
12/16/2010 |
PMCHK | $ | 3,596.89 | 5340 | No | Brad Cole | ||||||
12/2/2010 |
PMCHK | $ | 3,901.50 | 5316 | No | Corporation Service Company | ||||||
12/9/2010 |
PMCHK | $ | 3,500.00 | 5329 | No | Cynthia Tirpak | ||||||
12/16/2010 |
PMCHK | $ | 500.00 | 5341 | No | Cynthia Tirpak | ||||||
12/2/2010 |
PMCHK | $ | 115.64 | 5315 | No | David Carlson | ||||||
12/16/2010 |
PMCHK | $ | 1,152.44 | 5337 | No | David Carlson | ||||||
12/2/2010 |
PMCHK | $ | 38,631.77 | 5317 | No | Dickstein Shapiro LLP | ||||||
12/16/2010 |
PMCHK | $ | 18,525.39 | 5338 | No | Dickstein Shapiro LLP | ||||||
12/2/2010 |
PMCHK | $ | 1,235.00 | 5318 | No | Herman Technology Consultants-LLC | ||||||
12/9/2010 |
PMCHK | $ | 2,689.32 | 5326 | No | Herman Technology Consultants-LLC | ||||||
12/2/2010 |
PMCHK | $ | 5,869.96 | 5319 | No | Integrated Commercialization Sol. | ||||||
12/9/2010 |
PMCHK | $ | 200.00 | 5327 | No | PayFlex Systems USA, Inc. | ||||||
12/2/2010 |
PMCHK | $ | 99.00 | 5320 | No | Precision IR Group | ||||||
12/2/2010 |
PMCHK | $ | 451.00 | 5321 | No | Pure Compliance | ||||||
12/9/2010 |
PMCHK | $ | 50.00 | 5328 | No | Shred-it USA, DBA Shred-it Dallas | ||||||
12/2/2010 |
PMCHK | $ | 29,865.75 | 5322 | No | Tricare Management Activity | ||||||
12/17/2010 |
PMCHK | $ | 490.59 | 5342 | No | Verizon Wireless | ||||||
12/9/2010 |
PMCHK | $ | 871.30 | 5330 | No | VSP - (AT) | ||||||
12/2/2010 |
PMCHK | $ | 3,192.00 | 5323 | No | William Gallagher Associates | ||||||
12/9/2010 |
PMCHK | $ | 4,400.00 | 5331 | No | WINSTON & STRAWN LLP | ||||||
12/9/2010 |
PMCHK | $ | 125.39 | 5332 | No | WorldWide express | ||||||
12/16/2010 |
PMCHK | $ | 354.65 | 5339 | No | WorldWide express | ||||||
$ | 227,846.30 | Checks Cut | ||||||||||
Debits to bank other than checks | ||||||||||||
Transaction | Customer | |||||||||||
Date | Description | Amount | Bank Ref# | Ref. # | Payee / Description | |||||||
12/3/2010 |
ADP Payroll Fees | $ | 278.78 | OEX000001241 | ADP | |||||||
12/24/2010 |
ADP Payroll Fees | $ | 659.79 | WDL000001250 | ADP | |||||||
12/13/2010 |
Payroll | $ | 14,435.78 | OEX000001245 | ADP | |||||||
12/28/2010 |
Payroll | $ | 14,435.77 | WDL000001247 | ADP | |||||||
12/29/2010 |
Payroll Taxes | $ | 5,738.85 | WDL000001248 | ADP | |||||||
12/31/2010 |
Bank Fees | $ | 88.02 | OEX000001246 | Capital One | |||||||
12/30/2010 |
Rent | $ | 4,500.00 | WDL000001249 | Maguire Partners | |||||||
$ | 40,136.99 | Debits to Bank other than Checks | ||||||||||
Voided
Checks from Prior Periods |
$ | 0.00 | ||||||||||
$ | 267,983.29 | Total disbursements | ||||||||||
Checks cleared by bank: | ||||||||||||
12/2/2010 |
DEBIT MEMO - CapOne | $ | 427.67 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
12/3/2010 |
DEBIT MEMO - CapOne | $ | 6,117.11 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
12/6/2010 |
DEBIT MEMO - CapOne | $ | 50.00 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
12/8/2010 |
DEBIT MEMO - CapOne | $ | 9,863.51 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
12/9/2010 |
DEBIT MEMO - CapOne | $ | 44,501.73 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
12/13/2010 |
DEBIT MEMO - CapOne | $ | 1,114.44 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
12/14/2010 |
DEBIT MEMO - CapOne | $ | 871.30 | CONTROL DISBURSEMENT/CLEARED CHECKS |
GL Posting | Checkbook | |||||||||||
Date | Source Document | Amount | CM Trx Number | Voided | Paid ToRcvd From | |||||||
12/15/2010 |
DEBIT MEMO - CapOne | $ | 33,826.07 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
12/16/2010 |
DEBIT MEMO - CapOne | $ | 7,900.00 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
12/17/2010 |
DEBIT MEMO - CapOne | $ | 713.04 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
12/20/2010 |
DEBIT MEMO - CapOne | $ | 103,343.26 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
12/21/2010 |
DEBIT MEMO - CapOne | $ | 2,272.83 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
12/22/2010 |
DEBIT MEMO - CapOne | $ | 154.47 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
12/23/2010 |
DEBIT MEMO - CapOne | $ | 18,880.04 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
12/24/2010 |
DEBIT MEMO - CapOne | $ | 4,096.89 | CONTROL DISBURSEMENT/CLEARED CHECKS | ||||||||
$ | 234,132.36 | |||||||||||
In re: MiddleBrook Pharmaceuticals, Inc.
|
Case No. 10-11485 | |
Debtor
|
Reporting Period: December 1 December 31, 2010 |
SCHEDULE OF PROFESSIONAL FEES AND EXPENSES PAID
This schedule is to include all retained professional payments from case inception to current month
This schedule is to include all retained professional payments from case inception to current month
Invoice Amount - | Invoice Amount - | Fees | Expenses | Objection | Check | Amount Paid | Year-To-Date | |||||||||||||||||||||||||||||||||||
Payee | Period Covered | Fees | Expenses | Approved | Approved | Deadline | Number | Date | Fees | Expenses | Fees | Expenses | ||||||||||||||||||||||||||||||
Alston & Bird LLP |
4/30 - 5/31/10 | $ | 255,194.00 | $ | 0.00 | $ | 255,194.00 | $ | 0.00 | 7/7/2010 | 5082 | 7/21/2010 | $ | 204,155.20 | $ | 0.00 | $ | 204,155.20 | $ | 0.00 | ||||||||||||||||||||||
Alston & Bird LLP |
4/30 - 5/31/10 | $ | 0.00 | $ | 5,825.95 | $ | 0.00 | $ | 5,825.95 | 7/7/2010 | 5085 | 7/22/2010 | $ | 0.00 | $ | 5,825.95 | $ | 0.00 | $ | 5,825.95 | ||||||||||||||||||||||
Alston & Bird LLP |
6/1 - 6/30/10 | $ | 129,621.50 | $ | 7,762.21 | $ | 129,621.50 | $ | 7,762.21 | 8/5/2010 | 5107 | 8/12/2010 | $ | 103,697.20 | $ | 7,762.21 | $ | 103,697.20 | $ | 7,762.21 | ||||||||||||||||||||||
Alston & Bird LLP |
7/1 - 7/31/10 | $ | 100,767.00 | $ | 1,689.29 | $ | 100,767.00 | $ | 1,689.29 | 9/3/2010 | 5170 | 9/8/2010 | $ | 80,613.60 | $ | 1,689.29 | $ | 80,613.60 | $ | 1,689.29 | ||||||||||||||||||||||
Alston & Bird LLP |
8/1 - 8/31/10 | $ | 99,230.00 | $ | 2,430.75 | $ | 99,230.00 | $ | 2,430.75 | 10/4/2010 | 5243 | 10/7/2010 | $ | 79,384.00 | $ | 2,430.75 | $ | 79,384.00 | $ | 2,430.75 | ||||||||||||||||||||||
Alston & Bird LLP |
4/30 - 7/31/10* | 11/1/2010 | 5263 | 10/27/2010 | $ | 97,116.50 | $ | 0.00 | $ | 97,116.50 | $ | 0.00 | ||||||||||||||||||||||||||||||
Alston & Bird LLP |
9/1 - 9/31/10 | $ | 104,208.00 | $ | 285.55 | $ | 104,208.00 | $ | 285.55 | 11/2/2010 | 5286 | 11/4/2010 | $ | 80,366.40 | $ | 285.55 | $ | 80,366.40 | $ | 285.55 | ||||||||||||||||||||||
Alston & Bird LLP |
10/1 - 10/31/10 | $ | 126,101.00 | $ | 2,337.07 | $ | 126,101.00 | $ | 2,337.07 | 12/6/2010 | 5333 | 12/9/2010 | $ | 100,880.80 | $ | 2,337.07 | $ | 100,880.80 | $ | 2,337.07 | ||||||||||||||||||||||
Alston & Bird LLP |
11/1 - 11/30/10 | $ | 181,712.18 | $ | 3,249.18 | 1/19/2011 | $ | 0.00 | $ | 0.00 | ||||||||||||||||||||||||||||||||
Alston & Bird LLP subtotal |
$ | 746,213.70 | $ | 20,330.82 | ||||||||||||||||||||||||||||||||||||||
Bayard, P.A. |
5/11 - 5/31/10 | $ | 35,663.00 | $ | 212.04 | $ | 35,663.00 | $ | 212.04 | 7/19/2010 | 5086 | 7/22/2010 | $ | 28,530.40 | $ | 212.04 | $ | 28,530.40 | $ | 212.04 | ||||||||||||||||||||||
Bayard, P.A. |
6/1 - 6/30/10 | $ | 29,506.00 | $ | 393.24 | $ | 28,306.00 | $ | 393.24 | 8/10/2010 | 5142 | 8/17/2010 | $ | 22,644.80 | $ | 393.24 | $ | 22,644.80 | $ | 393.24 | ||||||||||||||||||||||
Bayard, P.A. |
7/1 - 7/31/10 | $ | 24,458.00 | $ | 623.21 | $ | 24,458.00 | $ | 623.21 | 9/7/2010 | 5212 | 9/14/2010 | $ | 19,566.40 | $ | 623.21 | $ | 19,566.40 | $ | 623.21 | ||||||||||||||||||||||
Bayard, P.A. |
8/1 - 8/31/10 | $ | 14,119.00 | $ | 366.86 | $ | 14,119.00 | $ | 366.86 | 10/7/2010 | 5257 | 10/20/2010 | $ | 11,295.20 | $ | 366.86 | $ | 11,295.20 | $ | 366.86 | ||||||||||||||||||||||
Bayard, P.A. |
4/30 - 7/31/10* | 10/19/2010 | 5275 | 10/27/2010 | $ | 17,685.40 | $ | 0.00 | $ | 17,685.40 | $ | 0.00 | ||||||||||||||||||||||||||||||
Bayard, P.A. |
9/1 - 9/31/10 | $ | 10,673.50 | $ | 287.15 | $ | 10,673.50 | $ | 287.15 | 11/2/2010 | 5291 | 11/17/2010 | $ | 8,538.80 | $ | 287.15 | $ | 8,538.80 | $ | 287.15 | ||||||||||||||||||||||
Bayard, P.A. |
10/1 - 10/31/10 | $ | 6,568.50 | $ | 191.38 | $ | 6,568.50 | $ | 191.38 | 12/14/2010 | 5345 | 1/6/2011 | $ | 5,254.80 | $ | 191.38 | $ | 5,254.80 | $ | 191.38 | ||||||||||||||||||||||
Bayard, P.A. |
11/1 - 11/30/10 | $ | 8,553.00 | $ | 201.93 | $ | 8,553.00 | $ | 201.93 | 1/5/2011 | 5433 | 1/13/2011 | $ | 6,842.40 | $ | 201.93 | $ | 6,842.40 | $ | 201.93 | ||||||||||||||||||||||
Bayard, P.A. subtotal |
$ | 120,358.20 | $ | 2,275.81 | ||||||||||||||||||||||||||||||||||||||
Carella, Byrne, Bain |
annuity services | $ | 450.00 | $ | 6,993.00 | $ | 450.00 | $ | 6,993.00 | N/A | 5044 | 7/2/2010 | $ | 450.00 | $ | 6,993.00 | $ | 450.00 | $ | 6,993.00 | ||||||||||||||||||||||
Carella, Byrne, Bain |
patent maintenance | $ | 50.00 | $ | 516.00 | $ | 50.00 | $ | 516.00 | N/A | 2588 | 6/21/2010 | $ | 50.00 | $ | 516.00 | $ | 50.00 | $ | 516.00 | ||||||||||||||||||||||
Carella, Byrne, Bain |
5/11 - 5/31/10 | $ | 43,716.00 | $ | 8,542.26 | $ | 43,716.00 | $ | 8,542.26 | 1/5/2011 | $ | 0.00 | $ | 0.00 | ||||||||||||||||||||||||||||
Carella, Byrne, Bain |
6/1 - 6/30/10 | $ | 56,689.50 | $ | 5,230.94 | $ | 56,689.50 | $ | 5,230.94 | 1/5/2011 | $ | 0.00 | $ | 0.00 | ||||||||||||||||||||||||||||
Carella, Byrne, Bain |
7/1 - 7/31/10 | $ | 51,815.50 | $ | 7,430.73 | $ | 51,815.50 | $ | 7,430.73 | 1/5/2011 | $ | 0.00 | $ | 0.00 | ||||||||||||||||||||||||||||
Carella, Byrne, Bain subtotal |
$ | 500.00 | $ | 7,509.00 | ||||||||||||||||||||||||||||||||||||||
Dickstein Shapiro LLP |
5/11 - 5/31/10 | $ | 134,068.50 | $ | 4,147.20 | $ | 134,068.50 | $ | 4,147.20 | 7/19/2010 | 5087 | 7/22/2010 | $ | 107,254.80 | $ | 4,147.20 | $ | 107,254.80 | $ | 4,147.20 | ||||||||||||||||||||||
Dickstein Shapiro LLP |
6/1 - 6/30/10 | $ | 63,546.50 | $ | 3,309.16 | $ | 63,546.50 | $ | 3,309.16 | 8/10/2010 | 5131 | 8/17/2010 | $ | 50,837.50 | $ | 3,309.16 | $ | 50,837.50 | $ | 3,309.16 | ||||||||||||||||||||||
Dickstein Shapiro LLP |
7/1 - 7/31/10 | $ | 63,076.25 | $ | 2,223.29 | $ | 63,076.25 | $ | 2,223.29 | 9/3/2010 | 5191 | 9/8/2010 | $ | 50,461.00 | $ | 2,223.29 | $ | 50,461.00 | $ | 2,223.29 | ||||||||||||||||||||||
Dickstein Shapiro LLP |
8/1 - 8/31/10 | $ | 28,955.00 | $ | 973.23 | $ | 28,955.00 | $ | 973.23 | 10/5/2010 | 5248 | 10/13/2010 | $ | 23,164.00 | $ | 973.23 | $ | 23,164.00 | $ | 973.23 | ||||||||||||||||||||||
Dickstein Shapiro LLP |
4/30 - 7/31/10* | 10/19/2010 | 5264 | 10/27/2010 | $ | 52,137.95 | $ | 0.00 | $ | 52,137.95 | $ | 0.00 | ||||||||||||||||||||||||||||||
Dickstein Shapiro LLP |
9/1 - 9/31/10 | $ | 43,782.00 | $ | 3,606.17 | $ | 43,782.00 | $ | 3,606.17 | 11/19/2010 | 5317 | 12/2/2010 | $ | 35,025.60 | $ | 3,606.17 | $ | 35,025.60 | $ | 3,606.17 | ||||||||||||||||||||||
Dickstein Shapiro LLP |
10/1 - 10/31/10 | $ | 23,127.00 | $ | 23.79 | $ | 23,127.00 | $ | 23.79 | 11/30/2010 | 5338 | 12/16/2010 | $ | 18,501.60 | $ | 23.79 | $ | 18,501.60 | $ | 23.79 | ||||||||||||||||||||||
Dickstein Shapiro LLP |
11/1 - 11/30/10 | $ | 17,037.00 | $ | 2,504.14 | $ | 17,037.00 | $ | 2,504.14 | 1/5/2011 | 5435 | 1/13/2011 | $ | 13,629.60 | $ | 2,504.14 | $ | 13,629.60 | $ | 2,504.14 | ||||||||||||||||||||||
Dickstein Shapiro LLP subtotal |
$ | 351,012.05 | $ | 16,786.98 | ||||||||||||||||||||||||||||||||||||||
Gleacher & Company |
4/30 - 7/31/10 | $ | 660,000.00 | $ | 52,514.48 | $ | 660,000.00 | $ | 52,514.48 | 9/7/2010 | Wire | 9/17/2010 | $ | 528,000.00 | $ | 52,514.48 | $ | 528,000.00 | $ | 52,514.48 | ||||||||||||||||||||||
Gleacher & Company |
4/30 - 7/31/10* | 9/30/2010 | 5240 | 10/20/2010 | $ | 132,000.00 | $ | 0.00 | $ | 132,000.00 | $ | 0.00 | ||||||||||||||||||||||||||||||
Gleacher & Company subtotal |
$ | 660,000.00 | $ | 52,514.48 | ||||||||||||||||||||||||||||||||||||||
Invotex, Inc. |
5/26 - 6/30/10 | $ | 71,248.50 | $ | 374.04 | $ | 71,248.50 | $ | 374.04 | 8/12/2010 | 5149 | 8/27/2010 | $ | 56,998.80 | $ | 374.04 | $ | 56,998.80 | $ | 374.04 | ||||||||||||||||||||||
Invotex, Inc. |
7/1 - 7/30/10 | $ | 14,514.25 | $ | 79.24 | $ | 14,514.25 | $ | 79.24 | 9/7/2010 | 5208 | 9/14/2010 | $ | 11,611.40 | $ | 79.24 | $ | 11,611.40 | $ | 79.24 | ||||||||||||||||||||||
Invotex, Inc. |
4/30 - 7/31/10* | 10/19/2010 | 5267 | 10/27/2010 | $ | 17,152.55 | $ | 0.00 | $ | 17,152.55 | $ | 0.00 | ||||||||||||||||||||||||||||||
Invotex, Inc. subtotal |
$ | 85,762.75 | $ | 453.28 | ||||||||||||||||||||||||||||||||||||||
Kurtzman Carson Consultants |
4/30/2010 | $ | 2,232.00 | $ | 78.20 | $ | 2,232.00 | $ | 78.20 | N/A | 5029 | 7/1/2010 | $ | 2,232.00 | $ | 78.20 | $ | 2,232.00 | $ | 78.20 | ||||||||||||||||||||||
Kurtzman Carson Consultants |
NYTIMES (July) | $ | 0.00 | $ | 3,680.00 | $ | 0.00 | $ | 3,680.00 | N/A | wire | 7/9/2010 | 0 | 3,680.00 | $ | 0.00 | $ | 3,680.00 | ||||||||||||||||||||||||
Kurtzman Carson Consultants |
5/1 - 5/31/10 | $ | 44,420.50 | $ | 13,040.83 | $ | 44,420.50 | $ | 13,040.83 | N/A | 5080 | 7/21/2010 | $ | 44,420.50 | $ | 13,040.83 | $ | 44,420.50 | $ | 13,040.83 | ||||||||||||||||||||||
Kurtzman Carson Consultants |
6/1 - 6/30/10 | $ | 25,815.50 | $ | 2,752.13 | $ | 25,815.50 | $ | 2,752.13 | N/A | 5096 | 7/27/2010 | $ | 25,815.50 | $ | 2,752.13 | $ | 25,815.50 | $ | 2,752.13 | ||||||||||||||||||||||
Kurtzman Carson Consultants |
7/1 -7/31/10 | $ | 20,333.00 | $ | 5,180.49 | $ | 20,333.00 | $ | 5,180.49 | N/A | 5150 | 8/27/2010 | $ | 20,333.00 | $ | 5,180.49 | $ | 20,333.00 | $ | 5,180.49 | ||||||||||||||||||||||
Kurtzman Carson Consultants |
8/1 -8/31/10 | $ | 15,765.50 | $ | 4,964.56 | $ | 15,765.50 | $ | 4,964.56 | N/A | 5221 | 9/23/2010 | $ | 15,765.50 | $ | 4,964.56 | $ | 15,765.50 | $ | 4,964.56 | ||||||||||||||||||||||
Kurtzman Carson Consultants |
9/1 -9/31/10 | $ | 9,943.00 | $ | 2,478.30 | $ | 9,943.00 | $ | 2,478.30 | N/A | 5268 | 10/27/2010 | $ | 9,943.00 | $ | 2,478.30 | $ | 9,943.00 | $ | 2,478.30 | ||||||||||||||||||||||
Kurtzman Carson Consultants |
10/1 - 10/31/10 | $ | 5,551.50 | $ | 1,284.34 | $ | 5,551.50 | $ | 1,284.34 | N/A | 5299 | 11/17/2010 | $ | 5,551.50 | $ | 1,284.34 | $ | 5,551.50 | $ | 1,284.34 | ||||||||||||||||||||||
Kurtzman Carson Consultants |
11/1 - 11/30/10 | $ | 11,821.00 | $ | 12,968.56 | $ | 11,821.00 | $ | 12,968.56 | N/A | 5347 | 1/6/2011 | $ | 11,821.00 | $ | 12,968.56 | $ | 11,821.00 | $ | 12,968.56 | ||||||||||||||||||||||
Kurtzman Carson Consultants subtotal |
$ | 135,882.00 | $ | 46,427.41 | ||||||||||||||||||||||||||||||||||||||
Morris James LLP |
7/1 - 7/31/10 | $ | 49,525.00 | $ | 256.57 | $ | 49,525.00 | $ | 256.57 | 9/20/2010 | 5227 | 9/23/2010 | $ | 39,620.00 | $ | 256.57 | $ | 39,620.00 | $ | 256.57 | ||||||||||||||||||||||
Morris James LLP |
8/1 - 8/31/10 | $ | 34,667.00 | $ | 466.80 | $ | 34,667.00 | $ | 466.80 | 10/27/2010 | 5285 | 11/4/2010 | $ | 27,733.60 | $ | 466.80 | $ | 27,733.60 | $ | 466.80 | ||||||||||||||||||||||
Morris James LLP |
9/1 - 9/31/10 | $ | 31,957.50 | $ | 650.33 | $ | 31,957.50 | $ | 650.33 | 11/8/2010 | 5302 | 11/17/2010 | $ | 25,566.00 | $ | 650.33 | $ | 25,566.00 | $ | 650.33 | ||||||||||||||||||||||
Morris James LLP |
10/1 - 10/31/10 | $ | 36,967.00 | $ | 697.22 | $ | 36,967.00 | $ | 697.22 | 12/23/2010 | 5348 | 1/6/2011 | $ | 29,573.60 | $ | 697.22 | $ | 29,573.60 | $ | 697.22 | ||||||||||||||||||||||
Morris James LLP subtotal |
$ | 122,493.20 | $ | 2,070.92 | ||||||||||||||||||||||||||||||||||||||
Young Conaway Stargatt & Taylor LLP |
4/30 - 5/31/10 | $ | 41,889.00 | $ | 0.00 | $ | 41,889.00 | $ | 0.00 | 7/16/2010 | 5083 | 7/21/2010 | $ | 33,511.20 | $ | 33,511.20 | ||||||||||||||||||||||||||
Young Conaway Stargatt & Taylor LLP |
4/30 - 5/31/10 | $ | 0.00 | $ | 1,099.45 | $ | 0.00 | $ | 1,099.45 | 7/16/2010 | 5088 | 7/22/2010 | $ | 1,099.45 | $ | 1,099.45 | ||||||||||||||||||||||||||
Young Conaway Stargatt & Taylor LLP |
6/1 - 6/30/10 | $ | 25,033.50 | $ | 636.75 | $ | 25,033.50 | $ | 636.75 | 8/9/2010 | 5129 | 8/12/2010 | $ | 20,026.80 | $ | 636.75 | $ | 20,026.80 | $ | 636.75 | ||||||||||||||||||||||
Young Conaway Stargatt & Taylor LLP |
7/1 - 7/31/10 | $ | 19,341.00 | $ | 1,717.81 | $ | 19,341.00 | $ | 1,717.81 | 8/31/2010 | 5190 | 9/8/2010 | $ | 15,472.80 | $ | 1,717.81 | $ | 15,472.80 | $ | 1,717.81 | ||||||||||||||||||||||
Young Conaway Stargatt & Taylor LLP |
4/30 - 7/31/10* | 10/19/2010 | 5274 | 10/27/2010 | $ | 17,152.70 | $ | 0.00 | $ | 17,152.70 | $ | 0.00 | ||||||||||||||||||||||||||||||
Young Conaway Stargatt & Taylor LLP |
8/1 - 8/31/10 | $ | 12,374.00 | $ | 477.75 | $ | 12,374.00 | $ | 477.75 | 11/3/2010 | 5287 | 11/4/2010 | $ | 9,899.20 | $ | 477.75 | $ | 9,899.20 | $ | 477.75 | ||||||||||||||||||||||
Young Conaway Stargatt & Taylor LLP |
9/1 - 9/31/10 | $ | 19,556.50 | $ | 1,097.91 | $ | 19,556.50 | $ | 1,097.91 | 11/12/2010 | 5306 | 11/17/2010 | $ | 15,645.20 | $ | 1,097.91 | $ | 15,645.20 | $ | 1,097.91 | ||||||||||||||||||||||
Young Conaway Stargatt & Taylor LLP |
10/1 - 10/31/10 | $ | 18,569.50 | $ | 420.28 | $ | 18,569.50 | $ | 420.28 | 12/22/2010 | 5355 | 1/6/2011 | $ | 14,855.60 | $ | 450.28 | $ | 14,855.60 | $ | 450.28 | ||||||||||||||||||||||
Young Conaway Stargatt & Taylor LLP subtotal |
$ | 126,563.50 | $ | 5,479.95 | ||||||||||||||||||||||||||||||||||||||
Total |
$ | 2,348,785.40 | $ | 153,848.65 | ||||||||||||||||||||||||||||||||||||||
* | Denotes Payment on remaining amounts due through quarterly filings. |
In re: MiddleBrook Pharmaceuticals, Inc.
|
Case No. 10-11485 | |
Debtor
|
Reporting Period: December 1 December 31, 2010 |
December | Cumulative | |||||||
2010 | Filing to Date | |||||||
Gross Sales |
$ | | $ | 438,100 | ||||
Sales Reserves and Allowances |
(8,377 | ) | 329,402 | |||||
Net Revenue |
$ | (8,377 | ) | $ | 767,502 | |||
Cost of Goods Sold |
$ | | $ | 860,166 | ||||
Salaries, Bonus & Temp Labor |
40,333 | 3,440,991 | ||||||
Benefits, Payroll Taxes, Recruiting
& Relocation |
(4,524 | ) | 125,159 | |||||
Subtotal: Salaries & Benefits |
$ | 35,809 | $ | 3,566,149 | ||||
Stock-Based Compensation |
| 408,171 | ||||||
Marketing & Advertising |
| 4,011 | ||||||
Travel & Entertainment |
8,033 | 65,068 | ||||||
Facilities and Equipment Related |
4,387 | 687,822 | ||||||
Insurance |
85,396 | 612,750 | ||||||
Distribution Expense |
0 | 359,749 | ||||||
Office & General Lab Supplies |
1,512 | 15,052 | ||||||
Consulting & Legal Fees |
504,165 | 3,934,125 | ||||||
Patents & Licensing |
(100 | ) | 214,513 | |||||
Audit, IR & Financial Fees |
12,900 | (29,135 | ) | |||||
Non-Income Taxes |
10,766 | 42,761 | ||||||
Depreciation and Amortization |
| 974,542 | ||||||
Director and SAB Fees |
| 64,771 | ||||||
Subtotal: FTE Expenses |
$ | 662,867 | $ | 10,920,349 | ||||
Marketing Costs |
(17,487 | ) | 152,088 | |||||
Direct Project Costs |
| 53,114 | ||||||
Total Expenses |
$ | 645,380 | $ | 11,985,717 | ||||
Income (Loss) from Operations |
$ | (653,757 | ) | $ | (11,218,215 | ) | ||
Interest Income |
6,928 | 29,417 | ||||||
Other income (expense) |
2,552 | 162,790 | ||||||
Net Income (Loss) Before Taxes |
$ | (644,277 | ) | $ | (11,026,009 | ) | ||
Net Income (Loss) |
$ | (646,451 | ) | $ | (11,026,009 | ) | ||
In re: MiddleBrook Pharmaceuticals, Inc.
|
Case No. 10-11485 | |
Debtor
|
Reporting Period: December 1 December 31, 2010 |
Current | Petition | |||||||
Month | Date | |||||||
Cash & Cash Equivalents |
$ | 16,264,005 | $ | 5,257,718 | ||||
Accounts Receivable, net |
| (490,487 | ) | |||||
Inventory |
| 2,213,158 | ||||||
Prepaid and Other Current Assets |
1,012,786 | 3,397,106 | ||||||
Property and Equipment |
| 14,341,773 | ||||||
Accumulated Depreciation |
| (12,460,925 | ) | |||||
Property and Equipment, net |
| 1,880,848 | ||||||
Deposits and Other Assets |
| 680,580 | ||||||
Intangible Assets |
| 11,877,529 | ||||||
Accum. Amort Intangibles |
| (2,643,218 | ) | |||||
Intangible Assets, net |
| 9,234,311 | ||||||
Total Assets |
$ | 17,276,791 | $ | 22,173,234 | ||||
Accounts Payable post-petition |
(527,251 | ) | | |||||
Accrued Payable to Lilly |
| | ||||||
Accrued Professional Fees |
(580,000 | ) | | |||||
Other Accrued Expenses |
(10,957 | ) | | |||||
Accounts Payable and Accrued Expenses Post-Petition |
(1,118,209 | ) | | |||||
Accounts Payable pre-petion |
(893,217 | ) | (1,214,588 | ) | ||||
Accrued Severance |
(2,432,458 | ) | (281,258 | ) | ||||
Accrued Payable to Lilly |
| (5,252 | ) | |||||
Accrued Professional Fees |
(30,000 | ) | (199,917 | ) | ||||
Accrued R&D Costs |
| (136,067 | ) | |||||
Accrued Keflex Copay Assistance |
| (9,276 | ) | |||||
Accrued Moxatag Copay Assistance |
| (3,705,035 | ) | |||||
Accrued Medicaid Rebates Payable |
| (563,001 | ) | |||||
Accrued Returns |
| (1,945,797 | ) | |||||
Other Accrued Expenses |
| (292,773 | ) | |||||
Wages Payable |
(232,412 | ) | (306,521 | ) | ||||
Employee Benefits Pay-401k |
| (33,339 | ) | |||||
Employee Benefits Flex Spending |
| (3,899 | ) | |||||
Other Current Liabilities |
(2,246,546 | ) | (4,810,772 | ) | ||||
Accounts Payable and Accrued Expenses Pre-Petition |
(5,834,632 | ) | (13,507,496 | ) | ||||
Deferred Contract Revenue non-current (pre-petition) |
(3,500,000 | ) | (11,625,000 | ) | ||||
Deferred Lease Expense |
| (18,340 | ) | |||||
Total Liabilities |
$ | (10,452,841 | ) | $ | (25,150,836 | ) | ||
Common Stock |
(865,119 | ) | (865,119 | ) | ||||
Additional Paid in Capital |
(322,373,995 | ) | (312,281,358 | ) | ||||
Retained Earnings |
288,505,818 | 299,240,744 | ||||||
YTD P&L |
27,909,346 | 16,883,336 | ||||||
Accumulated Deficit |
316,415,163 | 316,124,080 | ||||||
Stockholders Equity |
$ | (6,823,950 | ) | $ | 2,977,602 | |||
Liabilities & Stockholders Equity |
$ | (17,276,791 | ) | $ | (22,173,234 | ) |
In re: MiddleBrook Pharmaceuticals, Inc.
|
Case No. 10-11485 | |
Debtor
|
Reporting Period: December 1 December 31, 2010 |
Other Post-petition liabilities |
||||
Professional bankruptcy fees estimates corporate and local counsel |
$ | 270,000 | ||
Professional bankruptcy fees estimates equity committee counsel |
200,000 | |||
Professional bankruptcy fees estimates creditors committee cousel & FA |
100,000 | |||
Professional bankruptcy fees KCC estimate |
10,000 | |||
Total of Accrued Professional Fees (acct 21210) |
$ | 580,000 | ||
In re: MiddleBrook Pharmaceuticals, Inc.
|
Case No. 10-11485 | |
Debtor
|
Reporting Period: December 1 December 31, 2010 |
SUMMARY OF UNPAID POSTPETITION DEBTS
Vendor | Voucher | Document | Current Trx | Document | ||||||||||||||||||
ID | Vendor Name | Number | Date | Amount | Document Number | Type | Paid Date | |||||||||||||||
ALS002 |
Alston & Bird LLP | 038621 | 8/31/2010 | $ | 19,846.00 | AUG 20% | Invoice | |||||||||||||||
ALS002 |
Alston & Bird LLP | 038680 | 9/30/2010 | $ | 20,841.60 | SEP 20% | Invoice | |||||||||||||||
ALS002 |
Alston & Bird LLP | 038754 | 10/31/2010 | $ | 25,220.20 | OCT 20% | Invoice | |||||||||||||||
ALS002 |
Alston & Bird LLP | 038947 | 11/30/2010 | $ | 142,770.40 | NOV 80% | Invoice | |||||||||||||||
ALS002 |
Alston & Bird LLP | 038948 | 11/30/2010 | $ | 35,692.60 | NOV 20% | Invoice | |||||||||||||||
ALS002 |
Alston & Bird LLP | 038949 | 11/30/2010 | $ | 3,249.18 | NOV EXP | Invoice | |||||||||||||||
BAY002 |
Bayard, P.A. | 038641 | 8/31/2010 | $ | 2,823.80 | AUG 20% | Invoice | |||||||||||||||
BAY002 |
Bayard, P.A. | 038685 | 9/30/2010 | $ | 2,134.70 | SEP 20% | Invoice | |||||||||||||||
BAY002 |
Bayard, P.A. | 038766 | 10/31/2010 | $ | 1,313.70 | OCT 20% | Invoice | |||||||||||||||
BAY002 |
Bayard, P.A. | 038767 | 10/31/2010 | $ | 5,254.80 | OCT 80% | Invoice | 01/06/11 | ||||||||||||||
BAY002 |
Bayard, P.A. | 038768 | 10/31/2010 | $ | 191.38 | OCT EXP | Invoice | 01/06/11 | ||||||||||||||
BAY002 |
Bayard, P.A. | 038843 | 11/30/2010 | $ | 1,710.60 | NOV 20% | Invoice | |||||||||||||||
BAY003 |
Bayard, P.A. | 038844 | 11/30/2010 | $ | 6,842.40 | NOV 80% | Invoice | 01/13/11 | ||||||||||||||
BAY004 |
Bayard, P.A. | 038845 | 11/30/2010 | $ | 201.93 | NOV EXP | Invoice | 01/13/11 | ||||||||||||||
BET003 |
Betsy Price, Tax Assessor-Collector | 038672 | 12/31/2010 | $ | 5,363.72 | 00012721220 2010 | Invoice | |||||||||||||||
BET003 |
Betsy Price, Tax Assessor-Collector | 038741 | 12/31/2010 | $ | 420.01 | 00012721220 2010B | Invoice | |||||||||||||||
CAR002 |
Carella, Byrne, Bain | 038847 | 12/31/2010 | $ | 10,363.10 | JUL 20% | Invoice | |||||||||||||||
CAR002 |
Carella, Byrne, Bain | 038848 | 12/31/2010 | $ | 41,452.40 | JUL 80% | Invoice | |||||||||||||||
CAR002 |
Carella, Byrne, Bain | 038849 | 12/31/2010 | $ | 7,430.73 | JUL EXP | Invoice | |||||||||||||||
CAR002 |
Carella, Byrne, Bain | 038850 | 12/31/2010 | $ | 11,337.90 | JUN 20% | Invoice | |||||||||||||||
CAR002 |
Carella, Byrne, Bain | 038851 | 12/31/2010 | $ | 45,351.60 | JUN 80% | Invoice | |||||||||||||||
CAR002 |
Carella, Byrne, Bain | 038852 | 12/31/2010 | $ | 5,230.94 | JUN EXP | Invoice | |||||||||||||||
CAR002 |
Carella, Byrne, Bain | 038853 | 12/31/2010 | $ | 8,743.20 | MAY 20% | Invoice | |||||||||||||||
CAR002 |
Carella, Byrne, Bain | 038854 | 12/31/2010 | $ | 34,972.80 | MAY 80% | Invoice | |||||||||||||||
CAR002 |
Carella, Byrne, Bain | 038855 | 12/31/2010 | $ | 8,542.26 | MAY EXP | Invoice | |||||||||||||||
DEN002 |
Denton County Tax Office | 038717 | 12/31/2010 | $ | 511.58 | 2010 | Invoice | |||||||||||||||
DIC002 |
Dickstein Shapiro LLP | 038634 | 8/31/2010 | $ | 5,791.00 | AUG 20% | Invoice | |||||||||||||||
DIC002 |
Dickstein Shapiro LLP | 038746 | 9/30/2010 | $ | 8,756.40 | SEP 20% | Invoice | |||||||||||||||
DIC002 |
Dickstein Shapiro LLP | 038830 | 10/31/2010 | $ | 4,625.40 | OCT 20% | Invoice | |||||||||||||||
DIC002 |
Dickstein Shapiro LLP | 038856 | 11/30/2010 | $ | 3,407.40 | NOV 20% | Invoice | |||||||||||||||
DIC002 |
Dickstein Shapiro LLP | 038857 | 11/30/2010 | $ | 13,629.60 | NOV 80% | Invoice | 01/13/11 | ||||||||||||||
DIC002 |
Dickstein Shapiro LLP | 038858 | 11/30/2010 | $ | 2,504.14 | NOV EXP | Invoice | 01/13/11 | ||||||||||||||
MOR008 |
MORRIS JAMES LLP | 038563 | 7/31/2010 | $ | 9,905.00 | JULY FEES 20% | Invoice | |||||||||||||||
MOR008 |
MORRIS JAMES LLP | 038669 | 8/31/2010 | $ | 6,933.40 | AUG FEES 20% | Invoice | |||||||||||||||
MOR008 |
MORRIS JAMES LLP | 038689 | 9/30/2010 | $ | 6,391.50 | SEP 20% | Invoice | |||||||||||||||
MOR008 |
MORRIS JAMES LLP | 038823 | 10/31/2010 | $ | 7,393.40 | OCT 20% | Invoice | |||||||||||||||
YOU005 |
Young Conaway Stargatt & Taylor LLP | 038700 | 8/31/2010 | $ | 2,474.80 | AUG 20% | Invoice | |||||||||||||||
YOU005 |
Young Conaway Stargatt & Taylor LLP | 038719 | 9/30/2010 | $ | 3,911.30 | SEP EXP 20% | Invoice | |||||||||||||||
YOU005 |
Young Conaway Stargatt & Taylor LLP | 038787 | 10/31/2010 | $ | 3,713.90 | OCT 20% | Invoice | |||||||||||||||
$ | 527,250.77 | |||||||||||||||||||||
In re: MiddleBrook Pharmaceuticals, Inc.
|
Case No. 10-11485 | |
Debtor
|
Reporting Period: December 1 December 31, 2010 |
SUMMARY OF UNPAID POSTPETITION DEBTS
Attach aged listing of accounts payable.
Number of Days Past Due | ||||||||||||||||||||||||
Current | 0-30 | 31-60 | 61-90 | Over 90 | Total | |||||||||||||||||||
Accounts Payable |
$ | 6,295 | $ | | $ | | $ | | $ | | $ | 6,295 | ||||||||||||
Wages Payable (401k contributions) |
| | | | | | ||||||||||||||||||
Taxes Payable (payroll-related taxes) |
| | | | | | ||||||||||||||||||
Rent/Leases-Building |
| | | | | | ||||||||||||||||||
Rent/Leases-Equipment |
| | | | | | ||||||||||||||||||
Secured Debt/Adequate Protection Payments |
| | | | | | ||||||||||||||||||
Professional Fees* |
173,425 | 210,008 | 47,713 | 42,036 | 47,774 | 520,955 | ||||||||||||||||||
Amounts Due to Insiders** |
| | | | | | ||||||||||||||||||
Other:__________________________ |
| | | | | | ||||||||||||||||||
Other:__________________________ |
| | | | | | ||||||||||||||||||
Total Postpetition Debts |
$ | 179,720 | $ | 210,008 | $ | 47,713 | $ | 42,036 | $ | 47,774 | $ | 527,251 |
Explain how and when the Debtor intends to pay any past-due postpetition debts.
* | Professional fees are awaiting court approval or include remaining 20% of fees. |
|
** | Insider is defined in 11 U.S.C. Section 101(31). |
FORM MOR-4
(04/07)
(04/07)
In re: MiddleBrook Pharmaceuticals, Inc.
|
Case No. 10-11485 | |
Debtor
|
Reporting Period: December 1 December 31, 2010 |
ACCOUNTS RECEIVABLE RECONCILIATION AND AGING
Accounts Receivable Reconciliation | Amount | |||
Total Accounts Receivable at the beginning of the reporting period |
$ | 5,232.87 | ||
+ Amounts billed during the period |
| |||
- Amounts collected during the period |
| |||
- Other adjustments during period |
(5,232.87 | ) | ||
Total Accounts Receivable at the end of the reporting period |
|
Accounts Receivable Aging | Amount | |||
0 - 30 days old |
| |||
31 - 60 days old |
| |||
61 - 90 days old |
| |||
91 + days old |
| |||
Total Accounts Receivable |
| |||
Amount considered uncollectible (Bad Debt) |
||||
Accounts Receivable (Net) |
$ | |
DEBTOR QUESTIONNAIRE
Must be completed each month | Yes | No | ||
1. Have any assets been sold or transferred outside the normal course of business
this reporting period? If yes, provide an explanation below. |
X | |||
2. Have any funds been disbursed from any account other than a debtor in possession
account this reporting period? If yes, provide an explanation below. |
X | |||
3. Have all postpetition tax returns been timely filed? If no, provide an explanation
below. |
X | |||
4. Are workers compensation, general liability and other necessary insurance
coverages in effect? If no, provide an explanation below. |
X | |||
5. Has any bank account been opened during the reporting period? If yes, provide
documentation identifying the opened account(s). If an investment account has
been opened
provide the required documentation pursuant to the Delaware Local Rule 4001-3. |
X |
Debtor sold certain assets pursuant to the Order Establishing Procedures for the Sale and/or
abandonment of Certain Miscellaneous Property [Docket No. 263] dated September 7, 2010 (the
Order). See the page titled Sale of Assets for a listing of the miscellaneous property sold
during the current period pursuant to the Order
FORM MOR-5
(04/07)
(04/07)
In re: MiddleBrook Pharmaceuticals, Inc.
|
Case No. 10-11485 | |
Debtor
|
Reporting Period: December 1 December 31, 2010 |
SALE OF ASSETS
Relationship | ||||||||||||||
Date of | to | Purchase | ||||||||||||
Purchase | Purchaser | Debtor | Equipment | Model # | Serial # | Amount | ||||||||
12/8/2010 |
MarkOne | None | Cisco Catalyst 4507R | $ | 1,700.00 | |||||||||
12/8/2010 |
MarkOne | None | Cisco Catalyst 4506 | 1,275.00 | ||||||||||
12/8/2010 |
MarkOne | None | HP Proliant Server | 850.00 | ||||||||||
12/8/2010 |
MarkOne | None | HP Storageworks Modular SAN Array 1000 | 850.00 | ||||||||||
12/8/2010 |
MarkOne | None | APC Server Rack | 150.00 | ||||||||||
12/8/2010 |
MarkOne | None | APC Power Strips & Cords | 100.00 | ||||||||||
12/8/2010 |
MarkOne | None | Cisco ASA 5510 Series | 637.50 | ||||||||||
12/8/2010 |
MarkOne | None | APC Symmetra RM (Qty 3) $50 Each | 150.00 | ||||||||||
12/8/2010 |
MarkOne | None | 2 Samsung 22" Monitors | 170.00 | ||||||||||
12/8/2010 |
MarkOne | None | Cisco Catalyst 2950 | 127.50 | ||||||||||
12/8/2010 |
MarkOne | None | HP Proliant Server | 850.00 | ||||||||||
12/13/2011 |
Dan Gregory | None | Samsung TV | 300.00 | ||||||||||
12/13/2011 |
Dan Gregory | None | Infocus 1100 Projector | 300.00 | ||||||||||
12/13/2011 |
Dan Gregory | None | Lenovo X61 Laptop | 300.00 | ||||||||||
12/13/2011 |
Dan Gregory | None | Office Chair | 25.00 | ||||||||||
Total: | $ | 7,785.00 | ||||||||||||
STATUS OF POSTPETITION TAXES
The beginning tax liablitiy should be the ending liability from the prior month or, if this is the
first report, the amount should be zero.
Attach photocopies of IRS Form 6123 or payment receipt to verify payment or deposit of federal
payroll taxes
Attach photocopies of any tax returns filed during the reporting period
Amount | ||||||||||||||||||||||||
Beginning Tax | Withheld or | Check No. or | Ending Tax | |||||||||||||||||||||
Federal | Liability | Accrued | Amount Paid | Date Paid | EFT | Liability | ||||||||||||||||||
Withholding* |
$ | 5,219 | $ | 11,477 | $ | (5,739 | ) | 12/29/10 | EFT | $ | 10,957 | |||||||||||||
FICA-Employee* |
| | | | | |||||||||||||||||||
FICA-Employer* |
| | | | | |||||||||||||||||||
Unemployment |
| | | | | |||||||||||||||||||
Income |
| | | | | |||||||||||||||||||
Other: |
| | | | | |||||||||||||||||||
Total Federal Taxes |
5,219 | 11,477 | (5,739 | ) | | 10,957 | ||||||||||||||||||
State and Local |
||||||||||||||||||||||||
Withholding |
| | | | | |||||||||||||||||||
Sales |
| | | | | |||||||||||||||||||
Excise |
| | | | | |||||||||||||||||||
Unemployment |
| | | | | |||||||||||||||||||
Real Property |
6,295 | | | | 6,295 | |||||||||||||||||||
Personal Property |
| | | | | |||||||||||||||||||
Other: |
| | | | | |||||||||||||||||||
Total State and Local |
6,295 | | | | 6,295 | |||||||||||||||||||
Total Taxes |
$ | 11,514 | $ | 11,477 | $ | (5,739 | ) | $ | | $ | 17,252 |
* | Payroll taxes are paid to ADP |